Nova Eye Medical Ltd (ELXMF)
0.10
0.00 (0.00%)
USD |
OTCM |
May 03, 16:00
Nova Eye Medical Debt to Equity Ratio: 0.00 for June 30, 2023
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
Date | Value |
---|---|
June 30, 2023 | 0.00 |
December 31, 2022 | 0.0732 |
June 30, 2022 | 0.00 |
December 31, 2021 | 0.0604 |
June 30, 2021 | 0.0402 |
December 31, 2020 | 0.0892 |
June 30, 2020 | 0.0154 |
December 31, 2019 | 0.0296 |
June 30, 2019 | 0.2168 |
December 31, 2018 | 0.214 |
June 30, 2018 | 0.1953 |
December 31, 2017 | 0.2006 |
June 30, 2017 | 0.2674 |
December 31, 2016 | 0.1806 |
June 30, 2016 | 0.162 |
December 31, 2015 | 0.126 |
June 30, 2015 | 0.1594 |
December 31, 2014 | 0.1666 |
June 30, 2014 | 0.1545 |
December 31, 2013 | 0.1493 |
June 30, 2013 | 0.2375 |
December 31, 2012 | 0.2055 |
Date | Value |
---|---|
June 30, 2012 | 0.2438 |
December 31, 2011 | 0.2803 |
June 30, 2011 | 0.2779 |
December 31, 2010 | 0.2749 |
June 30, 2010 | 0.2819 |
December 31, 2009 | 0.3757 |
June 30, 2009 | 0.3473 |
December 31, 2008 | 0.4548 |
June 30, 2008 | 0.2186 |
December 31, 2007 | 0.1536 |
June 30, 2007 | 0.1441 |
December 31, 2006 | 0.155 |
June 30, 2006 | 0.0603 |
December 31, 2005 | 0.1534 |
June 30, 2005 | 0.1743 |
December 31, 2004 | 0.1301 |
June 30, 2004 | 0.0668 |
December 31, 2003 | 0.0745 |
June 30, 2003 | 0.0664 |
December 31, 2002 | 0.1182 |
June 30, 2002 | 0.0837 |
December 31, 2001 | 0.0661 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
Jun 2022
0.2168
Maximum
Jun 2019
0.0583
Average
0.0402
Median
Jun 2021
Debt to Equity Ratio Benchmarks
Alterity Therapeutics Ltd | -- |
Kazia Therapeutics Ltd | -- |
Immutep Ltd | -- |
Opthea Ltd | 0.00 |
Mesoblast Ltd | -- |
Debt to Equity Ratio Related Metrics
Total Assets (Quarterly) | 20.09M |
Total Liabilities (Quarterly) | 4.743M |
Shareholders Equity (Quarterly) | 15.35M |
Current Ratio | 2.327 |
Net Debt Paydown Yield | 2.62% |